183 related articles for article (PubMed ID: 33912168)
21. IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses.
Han JW; Sung PS; Hong SH; Lee H; Koh JY; Lee H; White S; Maslow JN; Weiner DB; Park SH; Jeong M; Heo J; Ahn SH; Shin EC
J Hepatol; 2020 Jul; 73(1):72-83. PubMed ID: 32088322
[TBL] [Abstract][Full Text] [Related]
22. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
[TBL] [Abstract][Full Text] [Related]
23. Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis.
Lario M; Muñoz L; Ubeda M; Borrero MJ; Martínez J; Monserrat J; Díaz D; Alvarez-Mon M; Albillos A
J Hepatol; 2013 Oct; 59(4):723-30. PubMed ID: 23742913
[TBL] [Abstract][Full Text] [Related]
24. Dynamic Changes in Ex Vivo T-Cell Function After Viral Clearance in Chronic HCV Infection.
Han JW; Sung PS; Kim KH; Hong SH; Shin EC; Jun Song M; Park SH
J Infect Dis; 2019 Sep; 220(8):1290-1301. PubMed ID: 31152667
[TBL] [Abstract][Full Text] [Related]
25. No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.
Cacoub P; Musset L; Hausfater P; Ghillani P; Fabiani FL; Charlotte F; Angevin E; Opolon P; Poynard T; Piette JC; Autran B
Clin Exp Immunol; 1998 Jul; 113(1):48-54. PubMed ID: 9697982
[TBL] [Abstract][Full Text] [Related]
26. The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders.
Jiang X; Song HJ; Wang W; Henry L; Childs-Kean LM; Re VL; Park H
J Manag Care Spec Pharm; 2021 Jul; 27(7):873-881. PubMed ID: 34185563
[No Abstract] [Full Text] [Related]
27. Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART.
Tanaskovic S; Fernandez S; Saraswati H; Yunihastuti E; Gani RA; Djauzi S; Price P
Viral Immunol; 2016 Apr; 29(3):176-83. PubMed ID: 27035638
[TBL] [Abstract][Full Text] [Related]
28. Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
Llorens-Revull M; Costafreda MI; Rico A; Guerrero-Murillo M; Soria ME; Píriz-Ruzo S; Vargas-Accarino E; Gabriel-Medina P; Rodríguez-Frías F; Riveiro-Barciela M; Perales C; Quer J; Sauleda S; Esteban JI; Bes M
PLoS One; 2021; 16(7):e0254243. PubMed ID: 34242330
[TBL] [Abstract][Full Text] [Related]
29. Impaired thymic output in patients with chronic hepatitis C virus infection.
Hartling HJ; Gaardbo JC; Ronit A; Salem M; Laye M; Clausen MR; Skogstrand K; Gerstoft J; Ullum H; Nielsen SD
Scand J Immunol; 2013 Oct; 78(4):378-86. PubMed ID: 23841696
[TBL] [Abstract][Full Text] [Related]
30. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient.
Hentzien M; Guihot A; de Maindreville D; Tabary T; Brodard V; Vieillard V; Adle-Biassette H; Bani-Sadr F
J Neurovirol; 2020 Aug; 26(4):607-610. PubMed ID: 32458280
[TBL] [Abstract][Full Text] [Related]
31. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
[TBL] [Abstract][Full Text] [Related]
32. Male Sexual Dysfunction Among Egyptian Patients with Chronic Hepatitis C Virus Infection Before and After Direct-Acting Antiviral Drugs.
Elshimi E; Morad W; Mohamad NE
J Sex Med; 2019 Mar; 16(3):402-409. PubMed ID: 30846113
[TBL] [Abstract][Full Text] [Related]
33. Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8
Vranjkovic A; Deonarine F; Kaka S; Angel JB; Cooper CL; Crawley AM
Front Immunol; 2019; 10():1926. PubMed ID: 31456810
[TBL] [Abstract][Full Text] [Related]
34. Lymphopenia in primary Sjögren's syndrome is associated with premature aging of naïve CD4+ T cells.
Fessler J; Fasching P; Raicht A; Hammerl S; Weber J; Lackner A; Hermann J; Dejaco C; Graninger WB; Schwinger W; Stradner MH
Rheumatology (Oxford); 2021 Feb; 60(2):588-597. PubMed ID: 32227243
[TBL] [Abstract][Full Text] [Related]
35. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
Anthony DD; Sulkowski MS; Smeaton LM; Damjanovska S; Shive CL; Kowal CM; Cohen DE; Bhattacharya D; Alston-Smith BL; Balagopal A; Wyles DL
J Infect Dis; 2020 Sep; 222(8):1334-1344. PubMed ID: 32406487
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of CD8
Lu X; Song B; Weng W; Su B; Wu H; Cheung AKL; Zhang T; Gao Y
Viral Immunol; 2023 Jan; 36(1):25-32. PubMed ID: 36346310
[TBL] [Abstract][Full Text] [Related]
38. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection.
Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S
Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965
[TBL] [Abstract][Full Text] [Related]
39. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis.
Girón-Ortega JA; Márquez-Coello M; Gutiérrez-Saborido D; Arizcorreta A; Cuesta-Sancho S; Girón-González JA
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1863-1871. PubMed ID: 33822285
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
Alsius M; Ferri MJ; Buxó M; López C; Serra I; Queralt X; Acero D
Gastroenterol Hepatol; 2019 Feb; 42(2):82-89. PubMed ID: 30446175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
